Fundraising FoxDamora Therapeutics
NASDAQ: DMRACopenhagen, US · 21 known investors
Find your way into Damora Therapeutics
Sign up to see every warm intro you have to Damora Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Damora Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Damora Therapeutics is a preclinical-stage biotechnology company that discovers and develops therapeutic candidates, including DMR-001, DMR-002, and DMR-003, with the goal of advancing treatments through investigational drug applications and clinical trials.
Founders & leadership
Board
Investors · 21
How we know: Access Biotechnology's portfolio page · Not right? Tell us
How we know: Viking Global's portfolio page · Not right? Tell us
How we know: stocktitan.net · Not right? Tell us
How we know: stocktitan.net · Not right? Tell us
How we know: the S-1 prospectus · board seat on SEC Form D · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: stocktitan.net · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
How we know: stocktitan.net · Not right? Tell us
Also in the syndicate · 6
Reported raises · per SEC filings
Form D private placements$428.3M disclosed across 3 of 6 rounds · 1900–2025
▶$285MraisedNov 2025 · 48 investors · BiotechnologyRule 506(b)
- Christopher CainDirector
- Garrett WinslowExecutive Officer
- Carl GoldfischerDirector
- Lori FirmaniExecutive Officer
- Peter HarwinDirector
- Amit MunshiDirector
- Hans T. SchambyeExecutive Officer, Director
- Jayson DallasDirector
- Julianne BrunoDirector
- Offering amount
- $285M
- Amount sold
- $285M
- Finders' fees
- $17.1M
- Placement agents
- UBS Securities LLC, Leerink Partners LLC, LifeSci Capital, LLC, Jefferies LLC
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$64.2MraisedNov 2020 · 42 investors · PharmaceuticalsRule 506(b)
- Jon FreveExecutive Officer
- Karen WagnerDirector
- Chandra LeoDirector
- Soren MollerDirector
- Soren LemoniusDirector
- Stephan ChristgauDirector
- David ShapiroDirector
- Chao Q. KhuongDirector
- Carl GoldfischerDirector
- Amit MunshiDirector
- Hans SchambyeExecutive Officer, Director
- Erez ChimovitsDirector
- Offering amount
- $64.2M
- Amount sold
- $64.2M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$79.1MraisedJan 2020 · 35 investors · PharmaceuticalsRule 506(b)
- Jakob Dynnes HansenExecutive Officer
- Hans SchambyeExecutive Officer
- Offering amount
- $123.7M
- Amount sold
- $79.1M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Frequently asked questions
- What does Damora Therapeutics do?
- Damora Therapeutics is a preclinical-stage biotechnology company that discovers and develops therapeutic candidates, including DMR-001, DMR-002, and DMR-003, with the goal of advancing treatments through investigational drug applications and clinical trials.
- Who are Damora Therapeutics's investors?
- Damora Therapeutics's investors include Access Biotechnology, Viking Global, Andreessen Horowitz, BAM Elevate, Bay City Capital, Commodore Capital, EIR Ventures, Forbion and 7 more.
- How much funding has Damora Therapeutics raised?
- Damora Therapeutics has disclosed $428.3M raised across 3 of its 6 known rounds.
- Where is Damora Therapeutics headquartered?
- Damora Therapeutics is headquartered in Copenhagen, US.